Hi Boffin.
I don’t want to make excuses for RAC, but I read the pre clinical results slightly differently.
With CCRCC, the result wasn’t statistically significant, despite showing signs of efficacy, but good rationale for this lack of significance is given, imho.
My reading of the MM, suggests a few different studies were undertaken. However it was “the novel in vivo” which didn’t work, because it sounds like the toxicity of the C’mib killed the mice before they can examine any cardiotoxic properties.
Hence the negatives for me are slow recruiting, hopefully Europe has the power to change this situation, Phil did suggest European delays at AGM given protocol changes to Euro trials.
thx
Please clarify if you think differently.
- Forums
- ASX - By Stock
- RAC
- Ann: Quarterly Activity Report & Appendix 4C
Ann: Quarterly Activity Report & Appendix 4C, page-59
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.78 |
Change
-0.040(2.20%) |
Mkt cap ! $302.5M |
Open | High | Low | Value | Volume |
$1.81 | $1.82 | $1.76 | $132.8K | 74.40K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 170 | $1.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.78 | 2 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4000 | 1.755 |
3 | 12714 | 1.750 |
1 | 3000 | 1.740 |
1 | 1405 | 1.720 |
4 | 25414 | 1.700 |
Price($) | Vol. | No. |
---|---|---|
1.780 | 3781 | 1 |
1.830 | 7500 | 1 |
1.840 | 1000 | 1 |
1.850 | 5222 | 1 |
1.880 | 2351 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |